Success Metrics

Completion Rate
0%(0/1)
Active Trials
1(14%)
Terminated
1(14%)

Phase Distribution

Ph phase_2
2
29%
Ph not_applicable
1
14%
Ph phase_3
1
14%
Ph phase_1
3
43%

Phase Distribution

3

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution7 total trials
Phase 1Safety & dosage
3(42.9%)
Phase 2Efficacy & side effects
2(28.6%)
Phase 3Large-scale testing
1(14.3%)
N/ANon-phased studies
1(14.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

7

all time

Status Distribution
Active(3)
Terminated(1)
Other(3)

Detailed Status

unknown3
Not yet recruiting2
Recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
1
Success Rate
0.0%
Most Advanced
Phase 3

Trials by Phase

Phase 13 (42.9%)
Phase 22 (28.6%)
Phase 31 (14.3%)
N/A1 (14.3%)

Trials by Status

not_yet_recruiting229%
recruiting114%
terminated114%
unknown343%

Recent Activity

Clinical Trials (7)

Drug Details

Intervention Type
RADIATION
Total Trials
7